7C88
| Complex structure of JS003 and PD-L1 | Descriptor: | JS003 Heavy chain, JS003 Light chain, Programmed cell death 1 ligand 1 | Authors: | Bi, X, Shi, R, Chai, Y, Qi, J, Yan, J, Tan, S. | Deposit date: | 2020-05-29 | Release date: | 2021-04-14 | Last modified: | 2024-10-09 | Method: | X-RAY DIFFRACTION (1.997 Å) | Cite: | Identification of a hotspot on PD-L1 for pH-dependent binding by monoclonal antibodies for tumor therapy. Signal Transduct Target Ther, 5, 2020
|
|
8SUO
| BA.2/AZD1061/AZD3152 structure analysis | Descriptor: | AZD1061 heavy chain, AZD1061 light chain, AZD3152 heavy chain, ... | Authors: | Oganesyan, V, van Dyk, N, Dippel, A, Barnes, A, O'Connor, E. | Deposit date: | 2023-05-12 | Release date: | 2024-05-15 | Last modified: | 2024-10-23 | Method: | X-RAY DIFFRACTION (3.3 Å) | Cite: | X-ray crystal structure of BA.2 RBD bound by two neutralizing antibodies To Be Published
|
|
8TV1
| Structure of the EphA2 LBDCRD bound to FabS1C_L1 | Descriptor: | 1,2-ETHANEDIOL, CHLORIDE ION, Ephrin type-A receptor 2, ... | Authors: | Singer, A.U, Bruce, H.A, Blazer, L, Adams, J.J, Sicheri, F, Sidhu, S.S. | Deposit date: | 2023-08-17 | Release date: | 2024-06-26 | Method: | X-RAY DIFFRACTION (2.6 Å) | Cite: | Synthetic Antibodies targeting EPHA2 Induce Diverse Signaling-Competent Clusters with Differential Activation To be published
|
|
8TRV
| Structure of the EphA2 LBDCRD bound to FabS1C_C1 | Descriptor: | 1,2-ETHANEDIOL, CHLORIDE ION, Ephrin type-A receptor 2, ... | Authors: | Singer, A.U, Bruce, H.A, Blazer, L, Adams, J.J, Sicheri, F, Sidhu, S.S. | Deposit date: | 2023-08-10 | Release date: | 2024-07-17 | Method: | X-RAY DIFFRACTION (3.25 Å) | Cite: | Synthetic Antibodies targeting EPHA2 Induce Diverse Signaling-Competent Clusters with Differential Activation To be Published
|
|
8TV2
| Structure of apo FabS1C_L1 | Descriptor: | CHLORIDE ION, S1C variant of Fab_L1 heavy chain, S1C variant of Fab_L1 light chain, ... | Authors: | Singer, A.U, Bruce, H.A, Blazer, L, Adams, J.J, Sicheri, F, Sidhu, S.S. | Deposit date: | 2023-08-17 | Release date: | 2024-07-31 | Method: | X-RAY DIFFRACTION (2.65 Å) | Cite: | Synthetic Antibodies targeting EPHA2 Induce Diverse Signaling-Competent Clusters with Differential Activation To be published
|
|
8TV5
| Structure of the EphA2 LBDCRD bound to FabS1CE_L1 in a 2:1 (EphA2 to Fab) ratio | Descriptor: | Ephrin type-A receptor 2, MAGNESIUM ION, S1CE variant of Fab_L1 heavy chain, ... | Authors: | Singer, A.U, Bruce, H.A, Blazer, L, Adams, J.J, Sicheri, F, Sidhu, S.S. | Deposit date: | 2023-08-17 | Release date: | 2024-09-11 | Last modified: | 2024-11-06 | Method: | X-RAY DIFFRACTION (4.6 Å) | Cite: | Synthetic Antibodies targeting EPHA2 Induce Diverse Signaling-Competent Clusters with Differential Activation To be published
|
|
7EY5
| |
7EYA
| |
7EY0
| |
7EZV
| |
7EY4
| Local CryoEM of the SARS-CoV-2 S6PV2 in complex with BD-667 | Descriptor: | BD-667 H, BD-667 L, Spike glycoprotein, ... | Authors: | Liu, P.L. | Deposit date: | 2021-05-29 | Release date: | 2021-09-08 | Last modified: | 2022-02-16 | Method: | ELECTRON MICROSCOPY (3.69 Å) | Cite: | Structures of SARS-CoV-2 B.1.351 neutralizing antibodies provide insights into cocktail design against concerning variants. Cell Res., 31, 2021
|
|
7F7H
| SARS-CoV-2 S protein RBD in complex with A8-1 Fab | Descriptor: | Heavy chain of A8-1 Fab, Light chain of A8-1 Fab, Spike glycoprotein S1 | Authors: | Dou, Y, Wang, X, Wang, K, Liu, P, Lu, B. | Deposit date: | 2021-06-29 | Release date: | 2022-06-15 | Last modified: | 2024-10-09 | Method: | X-RAY DIFFRACTION (3.19 Å) | Cite: | High throughput isolation of potent neutralizing antibodies from convalescent COVID-19 patients. To Be Published
|
|
8V4I
| Structure of bovine anti-HIV Fab ElsE1 | Descriptor: | ElsE1 Fab heavy chain, ElsE1 Fab light chain | Authors: | Stanfield, R.L, Wilson, I.A. | Deposit date: | 2023-11-29 | Release date: | 2024-09-04 | Last modified: | 2024-10-09 | Method: | X-RAY DIFFRACTION (1.81 Å) | Cite: | Immunization of cows with HIV envelope trimers generates broadly neutralizing antibodies to the V2-apex from the ultra-long CDRH3 repertoire To Be Published
|
|
8VS7
| Crystal structure of ADI-19425 Fab in complex with anti-idiotypic 2C1 Fab | Descriptor: | 1,2-ETHANEDIOL, 2C1 Heavy Chain, 2C1 Light Chain, ... | Authors: | Kher, G, Homad, L.J, McGuire, A.T, Pancera, M. | Deposit date: | 2024-01-23 | Release date: | 2024-09-18 | Last modified: | 2024-11-06 | Method: | X-RAY DIFFRACTION (2.41 Å) | Cite: | A novel RSV vaccine candidate derived from anti-idiotypic antibodies targets putative neutralizing B-cells in bulk PBMCs To Be Published
|
|
8VS8
| Crystal structure of ADI-19425 Fab in complex with anti-idiotypic 1D3 Fab | Descriptor: | 1D3 Heavy Chain, 1D3 Light Chain, ADI-19425 Heavy Chain, ... | Authors: | Kher, G, Homad, L.J, McGuire, A.T, Pancera, M. | Deposit date: | 2024-01-23 | Release date: | 2024-09-18 | Method: | X-RAY DIFFRACTION (2.67 Å) | Cite: | A novel RSV vaccine candidate derived from anti-idiotypic antibodies targets putative neutralizing B-cells in bulk PBMCs To Be Published
|
|
8VH3
| CH505.M5.G458Y CE2 Design SOSIP | Descriptor: | CH505.CE2 SOSIP gp120, CH505.CE2 SOSIP gp41 | Authors: | Henderson, R, Acharya, P. | Deposit date: | 2023-12-30 | Release date: | 2024-10-02 | Last modified: | 2024-11-06 | Method: | ELECTRON MICROSCOPY (3.9 Å) | Cite: | Engineering immunogens that select for specific mutations in HIV broadly neutralizing antibodies To Be Published
|
|
8V5S
| |
7WP6
| Cryo-EM structure of SARS-CoV-2 recombinant spike protein STFK in complex with three neutralizing antibodies | Descriptor: | 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, 36H6 heavy chain, ... | Authors: | Zheng, Q, Sun, H, Yuan, Q, Li, S, Xia, N. | Deposit date: | 2022-01-23 | Release date: | 2023-03-01 | Last modified: | 2023-09-13 | Method: | ELECTRON MICROSCOPY (3.81 Å) | Cite: | Lineage-mosaic and mutation-patched spike proteins for broad-spectrum COVID-19 vaccine. Cell Host Microbe, 30, 2022
|
|
7WP8
| Cryo-EM structure of SARS-CoV-2 recombinant spike protein STFK1628x in complex with three neutralizing antibodies | Descriptor: | 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, 2B4 heavy chain, ... | Authors: | Zheng, Q, Sun, H, Yuan, Q, Li, S, Xia, N. | Deposit date: | 2022-01-23 | Release date: | 2023-03-08 | Last modified: | 2024-10-09 | Method: | ELECTRON MICROSCOPY (3.88 Å) | Cite: | Lineage-mosaic and mutation-patched spike proteins for broad-spectrum COVID-19 vaccine. Cell Host Microbe, 30, 2022
|
|
7LFN
| Structure of Hyperglycosylated Human IgG1 Fc (Fc267_329) | Descriptor: | 2-acetamido-2-deoxy-beta-D-glucopyranose, IgG1 Fc (Fc267_329), alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, ... | Authors: | Fields, J.K, Sundberg, E.J. | Deposit date: | 2021-01-17 | Release date: | 2021-01-27 | Last modified: | 2024-10-23 | Method: | X-RAY DIFFRACTION (2.6 Å) | Cite: | Silent Antibodies: Generation of Hyperglycosylated FCs to Ablate Effector Functions To Be Published
|
|
7LF9
| Structure of Hyperglycosylated Human IgG1 Fc (Fc329) | Descriptor: | 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-alpha-D-mannopyranose-(1-6)-[alpha-D-mannopyranose-(1-3)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, IgG1 Fc (Fc329), ... | Authors: | Fields, J.K, Sundberg, E.J. | Deposit date: | 2021-01-15 | Release date: | 2021-01-27 | Last modified: | 2024-10-23 | Method: | X-RAY DIFFRACTION (2.2 Å) | Cite: | Silent Antibodies: Generation of Hyperglycosylated FCs to Ablate Effector Functions To Be Published
|
|
7LF5
| Structure of Hyperglycosylated Human IgG1 Fc (Fc267) | Descriptor: | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, IgG1 Fc (Fc267), alpha-L-fucopyranose, ... | Authors: | Fields, J.K, Sundberg, E.J. | Deposit date: | 2021-01-15 | Release date: | 2021-01-27 | Last modified: | 2024-11-06 | Method: | X-RAY DIFFRACTION (2.6 Å) | Cite: | Silent Antibodies: Generation of Hyperglycosylated FCs to Ablate Effector Functions To Be Published
|
|
7LBL
| Structure of Human IgG1 Fc | Descriptor: | Ig gamma-1 chain C region, beta-D-galactopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-alpha-D-mannopyranose-(1-6)-[2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-alpha-D-mannopyranose-(1-3)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose | Authors: | Fields, J.K, Sundberg, E.J. | Deposit date: | 2021-01-08 | Release date: | 2021-01-20 | Last modified: | 2024-11-06 | Method: | X-RAY DIFFRACTION (2.13 Å) | Cite: | Silent Antibodies: Generation of Hyperglycosylated FCs to Ablate Effector Functions To Be Published
|
|
7N0U
| Complex of recombinant Bet v 1 with Fab fragment of REGN5713 | Descriptor: | 2-acetamido-2-deoxy-beta-D-glucopyranose, REGN5713 Fab fragment heavy chain, REGN5713 Fab fragment light chain, ... | Authors: | Franklin, M.C, Romero Hernandez, A. | Deposit date: | 2021-05-26 | Release date: | 2021-08-11 | Last modified: | 2024-10-23 | Method: | X-RAY DIFFRACTION (3 Å) | Cite: | Targeting immunodominant Bet v 1 epitopes with monoclonal antibodies prevents the birch allergic response. J.Allergy Clin.Immunol., 149, 2022
|
|
7N0V
| |